220 related articles for article (PubMed ID: 16225604)
1. The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques.
Gordon KB; Bonish BK; Patel T; Leonardi CL; Nickoloff BJ
Br J Dermatol; 2005 Nov; 153(5):945-53. PubMed ID: 16225604
[TBL] [Abstract][Full Text] [Related]
2. Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation.
Marble DJ; Gordon KB; Nickoloff BJ
J Dermatol Sci; 2007 Nov; 48(2):87-101. PubMed ID: 17689932
[TBL] [Abstract][Full Text] [Related]
3. Effects of TNF-alpha inhibitors on the number of epidermal Langerhans cells in uninvolved skin of psoriatic patients: a pilot study.
Piaserico S; Zattra E; Michelotto A; Alaibac M
Acta Histochem; 2013 Sep; 115(7):767-9. PubMed ID: 23566554
[TBL] [Abstract][Full Text] [Related]
4. Effects of PUVA and mechlorethamine treatment of psoriatic patients on epidermal Langerhans' cells.
Torinuki W; Mauduit G; Haftek M; Thivolet J
Acta Derm Venereol; 1987; 67(6):532-5. PubMed ID: 2451383
[TBL] [Abstract][Full Text] [Related]
5. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
[TBL] [Abstract][Full Text] [Related]
6. Adalimumab therapy rapidly inhibits p38 mitogen-activated protein kinase activity in lesional psoriatic skin preceding clinical improvement.
Soegaard-Madsen L; Johansen C; Iversen L; Kragballe K
Br J Dermatol; 2010 Jun; 162(6):1216-23. PubMed ID: 20346019
[TBL] [Abstract][Full Text] [Related]
7. Langerhans cell markers CD1a and CD207 are the most rapidly responding genes in lesional psoriatic skin following adalimumab treatment.
Raaby L; Rosada C; Langkilde A; Lauridsen KL; Vinter H; Ommen P; Kjellerup RB; Johansen C; Iversen L
Exp Dermatol; 2017 Sep; 26(9):804-810. PubMed ID: 28109175
[TBL] [Abstract][Full Text] [Related]
8. The epidermal Langerhans' cell population in psoriasis during topical coal tar therapy.
Puttick LM; Johnson GD; Walker L
Acta Derm Venereol; 1986; 66(4):343-6. PubMed ID: 2430408
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha and interleukin-17 differently affects Langerhans cell distribution and activation in an innovative three-dimensional model of normal human skin.
Prignano F; Arnaboldi F; Cornaghi L; Landoni F; Tripo L; Preis FW; Donetti E
Eur J Cell Biol; 2015 Feb; 94(2):71-7. PubMed ID: 25596626
[TBL] [Abstract][Full Text] [Related]
10. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
[TBL] [Abstract][Full Text] [Related]
11. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
12. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
Oxholm A
APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
[TBL] [Abstract][Full Text] [Related]
13. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy.
Johansen C; Vinter H; Soegaard-Madsen L; Olsen LR; Steiniche T; Iversen L; Kragballe K
Br J Dermatol; 2010 Dec; 163(6):1194-204. PubMed ID: 20846304
[TBL] [Abstract][Full Text] [Related]
14. Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis.
Krüger-Krasagakis S; Galanopoulos VK; Giannikaki L; Stefanidou M; Tosca AD
Br J Dermatol; 2006 Mar; 154(3):460-6. PubMed ID: 16445776
[TBL] [Abstract][Full Text] [Related]
15. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
16. Infliximab restores the balance between pro- and anti-apoptotic proteins in regressing psoriatic lesions.
Kokolakis G; Giannikaki E; Stathopoulos E; Avramidis G; Tosca AD; Krüger-Krasagakis S
Br J Dermatol; 2012 Mar; 166(3):491-7. PubMed ID: 21985184
[TBL] [Abstract][Full Text] [Related]
17. Reduced density of T6-positive epidermal Langerhans' cells in uninvolved skin of patients with psoriasis.
Oxholm A; Oxholm P; Staberg B
Acta Derm Venereol; 1987; 67(1):8-11. PubMed ID: 2436422
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis.
Bosè F; Petti L; Diani M; Moscheni C; Molteni S; Altomare A; Rossi RL; Talarico D; Fontana R; Russo V; Altomare G; Reali E
Am J Pathol; 2013 Aug; 183(2):413-21. PubMed ID: 23731727
[TBL] [Abstract][Full Text] [Related]
19. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
[TBL] [Abstract][Full Text] [Related]
20. Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A.
Gupta AK; Baadsgaard O; Ellis CN; Voorhees JJ; Cooper KD
Arch Dermatol Res; 1989; 281(4):219-26. PubMed ID: 2673064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
